← Every firm
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. FDA Recalls
4 recalls on file across drugs, 0 of them Class I and 4 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (Class IIIApr 9, 2024Cross Contamination with Other Products |
| Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 5Class IIIApr 9, 2024Cross Contamination with Other Products |
| Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 5Class IIIApr 9, 2024Cross Contamination with Other Products |
| Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59Class IIIApr 9, 2024Cross Contamination with Other Products |